Re: Structural racism and inequity in cancer clinical trial participation: time for solutions
- PMID: 40257430
- PMCID: PMC12020723
- DOI: 10.1093/jncics/pkaf013
Re: Structural racism and inequity in cancer clinical trial participation: time for solutions
Conflict of interest statement
The authors have no conflicts to declare.
Comment on
-
Structural racism and inequity in cancer clinical trial participation: time for solutions.JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae089. doi: 10.1093/jncics/pkae089. JNCI Cancer Spectr. 2024. PMID: 39438028 Free PMC article. No abstract available.
References
-
- US Food and Drug Administration. Conducting clinical trials with decentralized elements: guidance for industry, investigaors and other interested parties. 2024. Accessed August 10, 2024. https://www.fda.gov/media/167696/download
-
- Stout NL, Nikcevich D, Henderson TO, et al. ; Alliance Rural Health Sub-Committee of the Community Oncology Committee members. Improving rural clinical trial enrollment: recommendations from the rural health working group of the alliance clinical trials network. J Clin Oncol. 2024;42:1722-1725. 10.1200/jco.23.01667 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources